Showing results (861-870 of 1,008) with videos related to
Sort By:
Pageof 101
Head & Neck|September 25, 2014
Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinomaMatthew E Spector, Steven B Chinn, Emily Bellile, et al.The Lancet. Oncology|May 14, 2021
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialAssuntina G Sacco, Ruifeng Chen, Francis P Worden, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2026
Systemic Treatment of Thyroid Cancer: ASCO GuidelineNabil F Saba, Nofisat Ismaila, Douglas Adkins, et al.Oral Oncology|February 26, 2014
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Jonathan B McHugh, et al.JAMA Otolaryngology-- Head & Neck Surgery|November 2, 2013
High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methodsHeather M Walline, Chris Komarck, Jonathan B McHugh, et al.Head & Neck|March 17, 2012
Head and neck squamous cell carcinoma in pregnant womenAnna M Eliassen, Samantha J Hauff, Alice L Tang, et al.Nutrition and Cancer|March 14, 2019
Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell CarcinomaLaura S Rozek, Shama Virani, Emily L Bellile, et al.The Laryngoscope|June 19, 2013
Biomarkers in advanced larynx cancerCarol R Bradford, Bhavna Kumar, Emily Bellile, et al.Head & Neck|August 6, 2013
Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomaMatthew E Spector, K Kelly Gallagher, Emily Bellile, et al.The Oncologist|May 31, 2022
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141Maura L Gillison, George Blumenschein, Jerome Fayette, et al.Pageof 101